Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Market Report

Global and China Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Industry Market Research Report (2017-2028)

  • POSTDATE：Nov 04, 2022
  • PAGES：215
  • REPORT CODE：GMM1345021
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • This report elaborates on the current development of the Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors industry thoroughly based on the international market dynamics and China's market situation.

    For a start, the report provides an in-depth analysis of the current market situation through three different aspects - by region, by type and by application, which includes market distribution of different types and applications, import and export analysis of major regions, development trends of different types of products in each region, market opportunities and market restrains of different applications.

    Secondly, this report lists the major players in the industry, displaying their market positions along with the strengths and weaknesses of their products, picturing the current competitive situation of the whole market. 

    Last but not least, the report analyzes and predicts the investment prospects and risks in the industry on the basis of industry data, combined with experts' opinions and suggestions.

    Please note that the figures and tables shown in the sample are just for the purpose of demonstration, which may differ from those in the final report.

    Competitive Landscape:

    • Astellas

    • Janssen Pharmaceuticals

    • Boehringer Ingelheim

    • Bristol Myers Squibb

    • Kotobuki Pharmaceutical

    • AstraZeneca

    • Eli Lilly

    Region:

    • China

    • North America

    • Europe

    • APAC

    • Latin America, Middle East and Africa

    Type:

    • Invokana (Canagliflozin)

    • Jardiance (Empagliflozin)

    • Farxiga/Forxiga (Dapagliflozin)

    • Suglat (Ipragliflozin)

    Application:

    • Hospital

    • Medical Research Institute

    • Other

  • Table of Content

    Chapter 1 Industry Overview & Development Status in Global and China Market

    • 1.1 Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Industry Overview

      • 1.1.1 Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Market Scope and Market Segments

      • 1.1.2 Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Industry Characteristics

      • 1.1.3 Global and China Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Volume and Growth Rate (2017-2028)

      • 1.1.4 Global and China Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Production Value and Growth Rate (2017-2028)

    • 1.2 Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Market Size and Growth Rate by Type (2017-2028)

      • 1.2.1 Invokana (Canagliflozin)

      • 1.2.2 Jardiance (Empagliflozin)

      • 1.2.3 Farxiga/Forxiga (Dapagliflozin)

      • 1.2.4 Suglat (Ipragliflozin)

    • 1.3 Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Market Size and Growth Rate by Application (2017-2028)

      • 1.3.1 Hospital

      • 1.3.2 Medical Research Institute

      • 1.3.3 Other

    • 1.4 Market Analysis by Region

      • 1.4.1 North America Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Consumption Market Size and Growth Rate (2017-2028)

      • 1.4.2 Europe Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Consumption Market Size and Growth Rate (2017-2028)

      • 1.4.3 APAC Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Consumption Market Size and Growth Rate (2017-2028)

      • 1.4.4 Latin America, Middle East and Africa Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Consumption Market Size and Growth Rate (2017-2028)

    • 1.5 Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)

      • 1.5.1 Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)

    • 1.6 China Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Volume, Price, Sales Value (2017-2028)

      • 1.6.1 China Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Volume, Price, Sales Value (2017-2028)

    Chapter 2 Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Market Trends and Competitive Landscape

    • 2.1 Market Trends and Dynamics

      • 2.1.1 Challenges and Restraints

      • 2.1.2 Opportunities and Potentialities

      • 2.1.3 Mergers and Acquisitions

    • 2.2 Competitive Landscape

      • 2.2.1 Market Concentration Rate Analysis

      • 2.2.2 Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Industry Porter's Five Forces Model Analysis

      • 2.2.3 Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Industry PEST Analysis

    • 2.3 Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Industry Chain Analysis

      • 2.3.1 Raw Material Supplies

      • 2.3.2 Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Downstream Market Analysis

      • 2.3.3 Upstream and Downstream Impacts on Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Industry

    Chapter 3 Global and China Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Market, by Manufacturer

    • 3.1 Global and China Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Volume, Sales Value and Market Share, by Manufacturer (2021&2022)

      • 3.1.1 Global and China Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Volume, by Manufacturer (2021&2022)

      • 3.1.2 Global and China Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Value, by Manufacturer (2021&2022)

      • 3.1.3 Global and China Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Market Share, by Manufacturer (2021&2022)

    • 3.2 SWOT Analysis on Global and China Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Market Top 3 Players

    Chapter 4 Global and China Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Market, by Type (2017-2028)

    • 4.1 Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Market Trend, by Type

    • 4.2 Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Volume, Sales Value, Market Share and Price Trend, by Type

      • 4.2.1 Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Volume and Market Share, by Type (2017-2028)

      • 4.2.2 Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Value and Market Share, by Type (2017-2028)

      • 4.2.3 Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Price Trend, by Type (2017-2028)

    • 4.3 China Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Volume, Sales Value, Market Share and Price Trend, by Type

      • 4.3.1 China Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Volume and Market Share, by Type (2017-2028)

      • 4.3.2 China Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Value and Market Share, by Type (2017-2028)

      • 4.3.3 China Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Price Trend, by Type (2017-2028)

    Chapter 5 Global and China Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Market, by Application (2017-2028)

    • 5.1 Downstream Market Overview

    • 5.2 Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Volume, Sales Value and Market Share, by Application

      • 5.2.1 Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Volume and Market Share, by Application (2017-2028)

      • 5.2.2 Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Value and Market Share, by Application (2017-2028)

    • 5.3 China Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Volume, Sales Value and Market Share, by Application

      • 5.3.1 China Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Volume and Market Share, by Application (2017-2028)

      • 5.3.2 China Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Value and Market Share, by Application (2017-2028)

    Chapter 6 Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Production, Import, Consumption and Export, by Region (2017-2022)

    • 6.1 China Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Production, Import, Consumption and Export (2017-2022)

    • 6.2 North America Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Production, Import, Consumption and Export (2017-2022)

    • 6.3 Europe Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Production, Import, Consumption and Export (2017-2022)

    • 6.4 APAC Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Production, Import, Consumption and Export (2017-2022)

    • 6.5 Latin America, Middle East and Africa Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Production, Import, Consumption and Export (2017-2022)

    Chapter 7 North America Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Market Analysis

    • 7.1 North America Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Market, by Type

    • 7.2 North America Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Market, by Application

    • 7.3 North America Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Market Analysis and Forecast, by Country

      • 7.3.1 United States Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 7.3.2 Canada Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 7.3.3 Mexico Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Volume, Sales Value and Growth Rate (2017-2028)

    Chapter 8 Europe Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Market Analysis

    • 8.1 Europe Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Market, by Type

    • 8.2 Europe Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Market, by Application

    • 8.3 Europe Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Market Analysis and Forecast, by Country

      • 8.3.1 Germany Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.2 UK Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.3 France Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.4 Italy Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.5 Nordic Countries Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.6 Spain Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.7 Belgium Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.8 Poland Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.9 Russia Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.10 Turkey Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Volume, Sales Value and Growth Rate (2017-2028)

    Chapter 9 APAC Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Market Analysis

    • 9.1 APAC Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Market, by Type

    • 9.2 APAC Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Market, by Application

    • 9.3 APAC Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Market Analysis and Forecast, by Country

      • 9.3.1 China Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.2 Japan Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.3 Australia and New Zealand Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.4 India Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.5 ASEAN Countries Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.6 South Korea Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Volume, Sales Value and Growth Rate (2017-2028)

    Chapter 10 Latin America, Middle East and Africa Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Market Analysis

    • 10.1 Latin America, Middle East and Africa Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Market, by Type

    • 10.2 Latin America, Middle East and Africa Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Market, by Application

    • 10.3 Latin America, Middle East and Africa Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Market Analysis and Forecast, by Country

      • 10.3.1 GCC Countries Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 10.3.2 Brazil Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 10.3.3 Nigeria Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 10.3.4 South Africa Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 10.3.5 Argentina Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Volume, Sales Value and Growth Rate (2017-2028)

    Chapter 11 Global and China Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Company Profiles

      • 11.1 Astellas

        • 11.1.1 Astellas Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.1.2 Astellas Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Product Profiles, Application and Specification

        • 11.1.3 Astellas Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.2 Janssen Pharmaceuticals

        • 11.2.1 Janssen Pharmaceuticals Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.2.2 Janssen Pharmaceuticals Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Product Profiles, Application and Specification

        • 11.2.3 Janssen Pharmaceuticals Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.3 Boehringer Ingelheim

        • 11.3.1 Boehringer Ingelheim Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.3.2 Boehringer Ingelheim Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Product Profiles, Application and Specification

        • 11.3.3 Boehringer Ingelheim Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.4 Bristol Myers Squibb

        • 11.4.1 Bristol Myers Squibb Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.4.2 Bristol Myers Squibb Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Product Profiles, Application and Specification

        • 11.4.3 Bristol Myers Squibb Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.5 Kotobuki Pharmaceutical

        • 11.5.1 Kotobuki Pharmaceutical Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.5.2 Kotobuki Pharmaceutical Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Product Profiles, Application and Specification

        • 11.5.3 Kotobuki Pharmaceutical Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.6 AstraZeneca

        • 11.6.1 AstraZeneca Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.6.2 AstraZeneca Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Product Profiles, Application and Specification

        • 11.6.3 AstraZeneca Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.7 Eli Lilly

        • 11.7.1 Eli Lilly Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.7.2 Eli Lilly Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Product Profiles, Application and Specification

        • 11.7.3 Eli Lilly Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    Chapter 12 Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Industry Investment Prospect and Risk Assessment

    • 12.1 Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Industry Investment Prospect Assessment

      • 12.1.1 Investment Opportunities in Segmented Markets

      • 12.1.2 Investment Opportunities in Regional Markets

      • 12.1.3 Investment Opportunities in Subdivided Industries

    • 12.2 Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Industry Investment Risk Assessment

      • 12.2.1 Competitive Risk Analysis

      • 12.2.2 Technology Risk Analysis

      • 12.2.3 Policies and Enterprise System Risk Analysis

    List of Tables and Figures

    • Figure Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Volume and Growth Rate (2017-2028)

    • Figure China Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Volume and Growth Rate (2017-2028)

    • Figure Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Production Value and Growth Rate (2017-2028)

    • Figure China Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Production Value and Growth Rate (2017-2028)

    • Figure Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Market Size and Growth Rate of Invokana (Canagliflozin) (2017-2028)

    • Figure Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Market Size and Growth Rate of Jardiance (Empagliflozin) (2017-2028)

    • Figure Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Market Size and Growth Rate of Farxiga/Forxiga (Dapagliflozin) (2017-2028)

    • Figure Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Market Size and Growth Rate of Suglat (Ipragliflozin) (2017-2028)

    • Figure Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Market Size and Growth Rate of Hospital (2017-2028)

    • Figure Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Market Size and Growth Rate of Medical Research Institute (2017-2028)

    • Figure Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Market Size and Growth Rate of Other (2017-2028)

    • Figure North America Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Consumption Market Size and Growth Rate (2017-2028)

    • Figure Europe Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Consumption Market Size and Growth Rate (2017-2028)

    • Figure APAC Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Consumption Market Size and Growth Rate (2017-2028)

    • Figure Latin America, Middle East and Africa Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Consumption Market Size and Growth Rate (2017-2028)

    • Figure Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)

    • Figure China Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Volume, Price, Sales Value (2017-2028)

    • Figure Porter's Five Forces Model Analysis

    • Figure Industry PEST Analysis

    • Table Global and China Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Volume, by Manufacturer (2021&2022)

    • Table Global and China Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Value, by Manufacturer (2021&2022)

    • Table Global and China Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Market Share, by Manufacturer (2021&2022)

    • Figure Global and China Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Market Share, by Manufacturer in 2021

    • Figure Global and China Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Market Share, by Manufacturer in 2022

    • Table Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Volume, by Type (2017-2028)

    • Table Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Volume Share, by Type (2017-2028)

    • Figure Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Volume Share, by Type (2017-2028)

    • Table Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Value, by Type (2017-2028)

    • Table Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Value Share, by Type (2017-2028)

    • Figure Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Price Trend, by Type (2017-2028)

    • Table China Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Volume, by Type (2017-2028)

    • Table China Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Volume Share, by Type (2017-2028)

    • Figure China Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Volume Share, by Type (2017-2028)

    • Table China Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Value, by Type (2017-2028)

    • Table China Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Value Share, by Type (2017-2028)

    • Figure China Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Price Trend, by Type (2017-2028)

    • Table Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Volume, by Application (2017-2028)

    • Table Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Volume Share, by Application (2017-2028)

    • Figure Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Volume Share, by Application (2017-2028)

    • Table Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Value, by Application (2017-2028)

    • Table Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Value Share, by Application (2017-2028)

    • Figure Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Value Share, by Application (2017-2028)

    • Table China Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Volume, by Application (2017-2028)

    • Table China Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Volume Share, by Application (2017-2028)

    • Figure China Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Volume Share, by Application (2017-2028)

    • Table China Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Value, by Application (2017-2028)

    • Table China Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Value Share, by Application (2017-2028)

    • Figure China Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Value Share, by Application (2017-2028)

    • Figure China Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Production, Import, Consumption and Export (2017-2022)

    • Figure North America Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Production, Import, Consumption and Export (2017-2022)

    • Figure Europe Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Production, Import, Consumption and Export (2017-2022)

    • Figure APAC Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Production, Import, Consumption and Export (2017-2022)

    • Figure Latin America, Middle East and Africa Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Production, Import, Consumption and Export (2017-2022)

    • Table North America Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Volume, by Type (2017-2028)

    • Table North America Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Volume Share, by Type (2017-2028)

    • Figure North America Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Volume Share, by Type (2017-2028)

    • Table North America Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Volume, by Application (2017-2028)

    • Table North America Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Volume Share, by Application (2017-2028)

    • Figure North America Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Volume Share, by Application (2017-2028)

    • Figure United States Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Volume and Growth Rate (2017-2028)

    • Figure United States Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Value and Growth Rate (2017-2028)

    • Figure Canada Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Volume and Growth Rate (2017-2028)

    • Figure Canada Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Value and Growth Rate (2017-2028)

    • Figure Mexico Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Volume and Growth Rate (2017-2028)

    • Figure Mexico Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Value and Growth Rate (2017-2028)

    • Table Europe Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Volume, by Type (2017-2028)

    • Table Europe Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Volume Share, by Type (2017-2028)

    • Figure Europe Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Volume Share, by Type (2017-2028)

    • Table Europe Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Volume, by Application (2017-2028)

    • Table Europe Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Volume Share, by Application (2017-2028)

    • Figure Europe Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Volume Share, by Application (2017-2028)

    • Figure Germany Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Volume and Growth Rate (2017-2028)

    • Figure Germany Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Value and Growth Rate (2017-2028)

    • Figure UK Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Volume and Growth Rate (2017-2028)

    • Figure UK Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Value and Growth Rate (2017-2028)

    • Figure France Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Volume and Growth Rate (2017-2028)

    • Figure France Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Value and Growth Rate (2017-2028)

    • Figure Italy Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Volume and Growth Rate (2017-2028)

    • Figure Italy Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Value and Growth Rate (2017-2028)

    • Figure Nordic Countries Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Volume and Growth Rate (2017-2028)

    • Figure Nordic Countries Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Value and Growth Rate (2017-2028)

    • Figure Spain Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Volume and Growth Rate (2017-2028)

    • Figure Spain Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Value and Growth Rate (2017-2028)

    • Figure Belgium Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Volume and Growth Rate (2017-2028)

    • Figure Belgium Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Value and Growth Rate (2017-2028)

    • Figure Poland Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Volume and Growth Rate (2017-2028)

    • Figure Poland Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Value and Growth Rate (2017-2028)

    • Figure Russia Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Volume and Growth Rate (2017-2028)

    • Figure Russia Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Value and Growth Rate (2017-2028)

    • Figure Turkey Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Volume and Growth Rate (2017-2028)

    • Figure Turkey Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Value and Growth Rate (2017-2028)

    • Table APAC Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Volume, by Type (2017-2028)

    • Table APAC Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Volume Share, by Type (2017-2028)

    • Figure APAC Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Volume Share, by Type (2017-2028)

    • Table APAC Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Volume, by Application (2017-2028)

    • Table APAC Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Volume Share, by Application (2017-2028)

    • Figure APAC Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Volume Share, by Application (2017-2028)

    • Figure China Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Volume and Growth Rate (2017-2028)

    • Figure China Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Value and Growth Rate (2017-2028)

    • Figure Japan Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Volume and Growth Rate (2017-2028)

    • Figure Japan Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Value and Growth Rate (2017-2028)

    • Figure Australia and New Zealand Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Volume and Growth Rate (2017-2028)

    • Figure Australia and New Zealand Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Value and Growth Rate (2017-2028)

    • Figure India Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Volume and Growth Rate (2017-2028)

    • Figure India Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Value and Growth Rate (2017-2028)

    • Figure ASEAN Countries Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Volume and Growth Rate (2017-2028)

    • Figure ASEAN Countries Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Value and Growth Rate (2017-2028)

    • Figure South Korea Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Volume and Growth Rate (2017-2028)

    • Figure South Korea Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Value and Growth Rate (2017-2028)

    • Table Latin America, Middle East and Africa Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Volume, by Type (2017-2028)

    • Table Latin America, Middle East and Africa Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Volume Share, by Type (2017-2028)

    • Figure Latin America, Middle East and Africa Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Volume Share, by Type (2017-2028)

    • Table Latin America, Middle East and Africa Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Volume, by Application (2017-2028)

    • Table Latin America, Middle East and Africa Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Volume Share, by Application (2017-2028)

    • Figure Latin America, Middle East and Africa Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Volume Share, by Application (2017-2028)

    • Figure GCC Countries Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Volume and Growth Rate (2017-2028)

    • Figure GCC Countries Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Value and Growth Rate (2017-2028)

    • Figure Brazil Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Volume and Growth Rate (2017-2028)

    • Figure Brazil Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Value and Growth Rate (2017-2028)

    • Figure Nigeria Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Volume and Growth Rate (2017-2028)

    • Figure Nigeria Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Value and Growth Rate (2017-2028)

    • Figure South Africa Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Volume and Growth Rate (2017-2028)

    • Figure South Africa Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Value and Growth Rate (2017-2028)

    • Figure Argentina Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Volume and Growth Rate (2017-2028)

    • Figure Argentina Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Value and Growth Rate (2017-2028)

    • Table Astellas Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Astellas Product Profiles, Application and Specification

    • Table Astellas Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Janssen Pharmaceuticals Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Janssen Pharmaceuticals Product Profiles, Application and Specification

    • Table Janssen Pharmaceuticals Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Boehringer Ingelheim Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Boehringer Ingelheim Product Profiles, Application and Specification

    • Table Boehringer Ingelheim Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Bristol Myers Squibb Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Bristol Myers Squibb Product Profiles, Application and Specification

    • Table Bristol Myers Squibb Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Kotobuki Pharmaceutical Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Kotobuki Pharmaceutical Product Profiles, Application and Specification

    • Table Kotobuki Pharmaceutical Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table AstraZeneca Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table AstraZeneca Product Profiles, Application and Specification

    • Table AstraZeneca Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Eli Lilly Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Eli Lilly Product Profiles, Application and Specification

    • Table Eli Lilly Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US